Cell Genesys is well positioned to manufacture products for Phase 3 clinical trials and potential commercial launch of its lead product development program, GVAX® immunotherapy for prostate cancer. Cell Genesys has built a 51,000 square-foot GMP (Good Manufacturing Practices) facility located in Hayward, CA.
